Gazyva Membranous Nephropathy Approval: Roche Wins First FDA Nod in PMN
FDA approves Roche Gazyva as the first drug for primary membranous nephropathy after MAJESTY showed 36% complete remission vs 6% with tacrolimus.
Tag: Gazyva
Read More